Table 1 Patients’ characteristics and their correlations with C1qA [276] genotype
Clinical Parameters | No.# | Genotype | P | Clinical Parameters | No.# | Genotype | P | ||
|---|---|---|---|---|---|---|---|---|---|
AA | AG + GG | AA | AG/GG | ||||||
Gender | Bulky mass | ||||||||
Male | 83 | 24 | 59 | 0.542 | ≥10 cm | 18 | 5 | 13 | 1.000 |
Female | 81 | 20 | 61 | <10 cm | 146 | 39 | 107 | ||
Age | Localized | ||||||||
≤60 | 102 | 26 | 76 | 0.620 | yes | 25 | 7 | 18 | 0.886 |
>60 | 62 | 18 | 44 | no | 139 | 37 | 102 | ||
B symptoms | No Extra Nodal Site | ||||||||
positive | 62 | 14 | 48 | 0.338 | ≤1 | 122 | 31 | 91 | 0.484 |
negative | 102 | 30 | 72 | >1 | 42 | 13 | 29 | ||
LDH | Incidence site | ||||||||
positive | 77 | 20 | 57 | 0.816 | lymph node | 93 | 25 | 68 | 0.986 |
negative | 87 | 24 | 63 | extralymph | 71 | 19 | 52 | ||
β2-MG | IPI | ||||||||
positive | 49 | 10 | 39 | 0.203 | 0~2 | 114 | 29 | 85 | 0.544 |
negative | 106 | 32 | 74 | 3~5 | 50 | 15 | 33 | ||
Stage | Molecular subtypes | ||||||||
I~II | 75 | 19 | 56 | 0.691 | GCB | 28 | 6 | 22 | 0.872 |
III~IV | 89 | 25 | 39 | non-GCB | 113 | 26 | 87 | ||